Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts1

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Transplantation

• Publication date

  2002-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00007890-200204150-00009PMID 11965033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse.

  2000cited by this paper
• INTRAGRAFT INTERLEUKIN-4 mRNA EXPRESSION AFTER SHORT-TERM CD154 BLOCKADE MAY TRIGGER DELAYED DEVELOPMENT OF TRANSPLANT ARTERIOSCLEROSIS IN THE ABSENCE OF CD8+ T CELLS1

  2000cited by this paper
• Interferon-γ elicits arteriosclerosis in the absence of leukocytes

  2000cited by this paper
• Interferon-gamma elicits arteriosclerosis in the absence of leukocytes.

  2000cited by this paper
• Direct and indirect recognition: the role of MHC antigens in graft rejection.

  1999cited by this paper
• Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice.

  1999cited by this paper
• Current knowledge of the pathogenesis of chronic allograft dysfunction.

  1999cited by this paper
• CD4 T cells can reject major histocompatibility complex class I‐incompatible skin grafts

  1999cited by this paper
• Chronic rejection and its risk factors.

  1999cited by this paper
• Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients.

  1998cited by this paper
• Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts.

  1998cited by this paper
• Endothelial activation and cytokine expression in human acute cardiac allograft rejection

  1998influential reference
• Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: evidence for tolerogenicity of donor resting B cells in vivo.

  1998cited by this paper
• Tolerance induction ameliorates allograft vasculopathy in rat aortic transplants. Influence of Fas-mediated apoptosis.

  1998cited by this paper
• Clinical outcome of renal transplantation. Factors influencing patient and graft survival.

  1998cited by this paper
• Influence of acute rejection episodes, HLA matching, and donor/recipient phenotype on the development of 'early' transplant-associated coronary artery disease.

  1997cited by this paper
• Tissue-specific expression of interleukin-4 induces extracellular matrix accumulation and extravasation of B cells.

  1997influential reference
• Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients.

  1997cited by this paper
• Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction.

  1997cited by this paper
• Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection.

  1997cited by this paper
• Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts.

  1997cited by this paper
• Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice.

  1997cited by this paper
• Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection.

  1996cited by this paper
• Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells.

  1996cited by this paper
• Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis.

  1995influential reference
• Comparative study of the role of professional versus semiprofessional or nonprofessional antigen presenting cells in the rejection of vascularized organ allografts.

  1995cited by this paper
• Immunopathology of cardiac transplant rejection

  1995cited by this paper
• Development of a mouse aortic transplant model of chronic rejection

  1995cited by this paper
• Pathology and etiology of chronic rejection of the heart

  1994cited by this paper
• The pathogenesis of coronary arteriosclerosis (“chronic rejection”) in transplanted hearts

  1994cited by this paper
• Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma.

  1994influential reference
• Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity.

  1994cited by this paper
• Chronic rejection.

  1994cited by this paper
• Risk factors for chronic rejection in renal allograft recipients.

  1993cited by this paper
• Constructing polycompetitor cDNAs for quantitative PCR.

  1993cited by this paper
• Nitric oxide--a new endogenous immunomodulator.

  1993cited by this paper
• Predictors of chronic rejection in renal transplant recipients.

  1993cited by this paper
• Transforming growth factor-beta in disease: the dark side of tissue repair.

  1992cited by this paper
• Tolerance and MHC restriction in transgenic mice expressing a MHC class I gene in erythroid cells.

  1992cited by this paper
• Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4.

  1992cited by this paper
• Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection.

  1992cited by this paper
• Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis.

  1991cited by this paper
• Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease.

  1991cited by this paper
• Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis.

  1989cited by this paper
• Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells.

  1989cited by this paper
• Problem of chronic rejection.

  1988cited by this paper
• Two types of mouse helper T-cell clone Implications for immune regulation.

  1987cited by this paper
• A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication.

  1981cited by this paper
• Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens

  1978cited by this paper

• Repeated CXCR4 Blockade by Plerixafor Attenuates Transplant Vasculopathy in Murine Aortic Allografts.

  2024cites this paper
• Nintedanib reduces alloimmune-induced chronic airway changes in murine tracheal allografts.

  2022cites this paper
• Role of CMV chemokine receptor M33 in airway graft rejection in a mouse transplant model.

  2021cites this paper
• Microvasculature in murine tracheal allografts after combined therapy with clopidogrel and everolimus.

  2021cites this paper
• Direct Impact of Human Platelets on the Development of Transplant Arteriosclerosis

  2021cites this paper
• Cytomegalovirus chemokine receptor M33 knockout reduces chronic allograft rejection in a murine aortic transplant model.

  2020cites this paper
• Preservation of Microvascular Integrity in Murine Orthotopic Tracheal Allografts by Clopidogrel

  2019cites this paper
• Visualization of Monocytic Cells in Regressing Atherosclerotic Plaques by Intravital 2-Photon and Positron Emission Tomography–Based Imaging—Brief Report

  2018cites this paper
• Effects of different serotonin receptor subtype antagonists on the development of cardiac allograft vasculopathy in murine aortic allografts.

  2018cites this paper
• Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts

  2018cites this paper
• Reduction of Transplant Vasculopathy by Intraoperative Nucleic Acid-based Therapy in a Mouse Aortic Allograft Model

  2018cites this paper
• Reduction of obliterative bronchiolitis (OB) by prolyl-hydroxylase-inhibitors activating hypoxia-inducible transcription factors in an experimental mouse model.

  2016cites this paper
• Cardiomyocytes display low mitochondrial priming and are highly resistant toward cytotoxic T‐cell killing

  2016cites this paper
• Prolyl-hydroxylase inhibitor activating hypoxia-inducible transcription factors reduce levels of transplant arteriosclerosis in a murine aortic allograft model.

  2016cites this paper
• Delayed therapy with clopidogrel and everolimus prevents progression of transplant arteriosclerosis and impairs humoral alloimmunity in murine aortic allografts.

  2015cites this paper
• B CELLS AND ANTIBODY IN THE DEVELOPMENT OF LONG-TERM CARDIAC GRAFT REJECTION

  2014cites this paper
• Clopidogrel reduces post‐transplant obliterative bronchiolitis

  2013cites this paper
• Procurement Regimens to Reduce Ischemia Reperfusion Injury of Vascular Grafts

  2012cites this paper
• Role of Matricellular Proteins in Cardiac Allograft Fibrosis

  2012cites this paper
• Human Cytomegalovirus Infection Leads to Elevated Levels of Transplant Arteriosclerosis in a Humanized Mouse Aortic Xenograft Model

  2012cites this paper
• Noninvasive Magnetic Resonance Imaging of Vessels Affected by Transplant Arteriosclerosis in an Experimental Mouse Aortic Allograft Model

  2011cites this paper
• Aorta transplantation in young apolipoprotein E-deficient mice: Possible model for studies on regression of atherosclerotic lesions?

  2010cites this paper
• Murine Cytomegalovirus Infection Leads to Increased Levels of Transplant Arteriosclerosis in a Murine Aortic Allograft Model

  2010cites this paper
• Combination of clopidogrel and everolimus dramatically reduced the development of transplant arteriosclerosis in murine aortic allografts

  2010cites this paper
• Inhibition of TNF‐α reduces transplant arteriosclerosis in a murine aortic transplant model

  2009cites this paper
• Unaltered levels of transplant arteriosclerosis in the absence of the B cell homing chemokine receptor CXCR5.

  2009cites this paper
• Attenuation of Transplant Arteriosclerosis With Clopidogrel Is Associated With a Reduction of Infiltrating Dendritic Cells and Macrophages in Murine Aortic Allografts

  2009cites this paper
• Donor HO-1 Expression Inhibits Intimal Hyperplasia in Unmanipulated Graft Recipients: A Potential Role for CD8+ T-Cell Modulation by Carbon Monoxide

  2009cites this paper
• Investigation into the onset and progression of transplant arteriosclerosis in a mice aortic retransplantation model

  2008cites this paper
• Neutralizing Interleukin-4 Prevents Transplant Arteriosclerosis Mediated by Indirect Pathway T Cells Under CD40-CD154 Costimulation Blockade

  2008cites this paper
• Modulation of graft arteriosclerosis in a rat carotid transplantation model.

  2008cites this paper
• Increased Transplant Arteriosclerosis in the Absence of CCR7 is Associated With Reduced Expression of Foxp3

  2008cites this paper
• Role of PECAM-1 in Acute Rejection of Fully Major Histocompatibility Complex Class II-Mismatched Cardiac Allografts in Mice

  2007cites this paper
• Clopidogrel reduziert die Entwicklung der Transplantat-Arteriosklerose im Mausmodell

  2007cites this paper
• Clopidogrel reduces the development of transplant arteriosclerosis.

  2006cites this paper
• Transplantation rénale : aspects immunologiques

  2006cites this paper
• lopidogrel reduces the development of transplant rteriosclerosis

  2006cites this paper
• Platelet-endothelial cell adhesion molecule-1 (CD31) expression on donor endothelial cells attenuates the development of transplant arteriosclerosis1

  2002cites this paper
• Critical Role for IL-4 in the Development of Transplant Arteriosclerosis in the Absence of CD40-CD154 Costimulation1

  2001cites this paper